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Summary
Human papillomavirus (HPV) is a virus often infecting humans. It is often present on skin or mucous 
membranes. These diverse DNA viruses are often linked to many various benign and malignant neoplastic 
lesions. Over 40 types of HPV are transmitted through sexual contact and infect the anogenital region 
which might be secondly transmitted to the oral mucous. Over 150 HPV viruses are defined according to 
the invaded site. Oral papillomas are marked with numbers 6, 7, 11, 16 and 32. Squamous cell papilloma 
is often found in laryngeal epithelial tumor associated with HPV-6 and HPV-11 and also HPV-16 in oral 
squamous cell carcinoma (OSCC). In the last 15 years OSCC has become more common in children and 
young adults. The role of HPV virus causing oral squamous cell carcinomas is more often realized, but 
people’s lack of knowledge and risky sexual behavior is still the main factor in growing HPV infections.
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IntroductIon
The oral cavity is a specific part of the human body. Because 
of its architecture and localization often many lesions and 
pathological changes can be diagnosed. Quite often the oral 
cavity is the first place of manifesting general diseases, such 
as leukemia or diabetes.  
Because of dangerous sexual behavior HPV infection might 
spread to the oral cavity and oropharyngeal regions. Sexu-
ally transmitted infections (STI) are related to HPV infec-
tions. Schwartz et al. reported that increasing number of 
sexual partners, young age and a history of genital warts 
are related to higher prevalence of transmission of HPV 
positive head and neck squamous cell carcinoma (HNSCC) 
in oral and oropharyngeal regions [47]. Studies performed 
by Mork et al. show that higher exposure to HPV-16 dra-
matically increases risk of squamous cell carcinoma (SCC) 611
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[38]. Many authors worldwide are studying the nature of 
HPV virus and its relation to oral SCC.
HPV virus can be present in healthy people, despite age, 
gender or other factors. It is also worth noting that syn-
dromes and diseases with less or lack of immunodeficien-
cies are also considered to be related not only to HPV 
infections, but also HSV (herpes simplex virus), EBV (Ep-
stein-Barr virus) and others.
HPV virus is also related to human immunodeficiency 
virus (HIV) [14]. Beachler et al. performed a study on 379 
HIV-positive and 266 at-risk HIV-negative individuals and 
tested for 36 types of HPV DNA with PGMY09/11 (prima-
ry PCR, polymerase chain reaction) primers and reverse 
line blot hybridization [3]. Studies showed that oral HPV 
prevalence was higher in HIV-positive individuals. It may 
depend on the stage of HIV infection. During those stud-
ies the authors found that oral HPV-16 was the most com-
monly discovered, and more often in HIV-negative (16%) 
than HIV-positive participants (8%). In a cross-sectional 
study the most common detected oncogenic HPV was 
16, 59 and 33, and non-oncogenic was HPV: 55, 62 and 53 
types. This relation may differ in geographical regions 
and cultural findings. Individual habits should also be 
considered.
Studies performed by Gillison et al. on 5579 participants in 
the USA showed that HPV-16 prevalence was 1.0% and oral 
HPV was 6.9% [15]. During studies a 30-second oral rinse 
and gargle with mouth wash was used. HPV was detected 
using PCR (polymerase chain reaction) and type-specific 
hybridization. HPV prevalence was higher among men 
than women aged 50 to 64 years old. Another important 
issue is that HPV infection was more common in sexually 
experienced individuals than among sexually inexperi-
enced. Therefore patient’s age, number of partners and 
sexual experience are among the main factors responsible 
for HPV infections related to sexual transmission. Never-
theless, uneducated young people are still considered the 
high-risk group [6,58].
Tobacco and alcohol along with HPV are related to head 
and neck squamous-cell carcinomas (HNSCC). A synergistic 
effect that might occur after combining both factors might 
increase the number of HNSCC. The well-known rate of all 
factors may vary depending on region, sexual behaviors or 
might be related to a combination of risk factors. Various 
authors discuss the potential role of HPV, since it cannot 
form an SCC on its own [4].
It seems that not only tobacco and alcohol might be re-
lated to SCC of the oral and oropharyngeal region. Both 
studies from the USA and Europe show that average age 
of sexual debut has decreased while the number of sex-
ual partners has increased over the years. Studies made 
by Agius in 2010 [1] seem to confirm this. Tendencies 
to perform oral sex between men and women vary in 
age, but younger and middle-aged both men and women 
seem to have over 45% more oral sex than older people 
[18]. HPV infection normally takes more than 10 years to 
progress from simple infection, sexual behavior changes 
to potential malignancy [7,13]. Therefore sexual educa-
tion should take place in younger patients and inform 
about potential threats of having more than one sexual 
partner. Women with cervical HPV infection have high-
er oral HPV prevalence than others, while according to 
Kreimer oral HPV-16 presence is found in 1.3% of healthy 
adults [26].
Kreimer et al. studies performed on 1688 young and 
healthy men aged from 18 to 74 suggest that several types 
of HPV are related to different risk factors [27]. In the study 
Roche Linear Array was used and about 12 types of HPV 
were recognized. Oral HPV-16 was the most commonly de-
tected and was detected in 1.3% of all studied individuals. 
HPV-16 is rarely present in younger ages, and was prob-
ably related to current tobacco use.
HPV-related HNSCC remains not fully described. Occur-
rence and localization of viral infections are still studied. 
Many authors claim that personal life and life style are very 
important factors of HPV-related HNSCC [51,57].
oral Scc
Oral squamous cell carcinoma (OSCC) and nasopharyngeal 
carcinoma (NPC) are commonly related to HPV infection 
and/or EBV virus (Epstein-Barr Virus). Variables of SCC 
might be present in the oral or nasopharyngeal region, 
but not so common at both sites at the same time. Ac-
cording to the newest studies, evidence shows that high-
risk HPV-16 has a specific role in the main cause of oro-
pharyngeal SCC. According to Marur et al., pharyngeal 
tonsils, soft palate and posterior third of the tongue are 
more common for squamous cell carcinoma [35]. More 
than 65% of oropharyngeal cancers are HPV positive, and 
because of that might have better prognosis than those 
that are HPV negative. Oral SCC is on the other hand more 
common on the anterior two thirds of the tongue, mouth 
floor, alveolus, gingiva, hard palate and buccal and labial 
mucosa [9, 31]. Place of occurrence might vary depend-
ing on exposure to risk factors in different anatomical 
parts of the oral cavity. Some studies have shown that 
HPV positive testing may vary in oropharyngeal sites and 
non-oropharyngeal sites [44]. The International Agency 
for Research on Cancer (IARC) concludes that the role of 
HPV in non-pharyngeal HNSCC in the general popula-
tion is less certain. Only lesser HPV influence might be 
correlated with oral cavity SCC [19]. Because of different 
opinions on HPV involvement in OSCC, a conclusion can 
be made that it might be related to occurrence in differ-
ent geographic regions.
In cohort analysis of 47 patients suffering from OSCC per-
formed by Sagredo et al., no HPV genomic DNA was de-
tected [45]. It might be a fact that HPV infection is tempo-
rary and related to malignant and premalignant lesions. 
On the other hand, OSCC was found on the tongue, mouth 
floor, oropharynx, gingiva and buccal mucosa. The authors 612
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used a simple method to diagnose, with use of a cytologi-
cal brush swabbed in the oral cavity and use of a single 
kit using the PCR method and targeting the L1 region of 
the viral genome.
HPV virus has many types and sub-types, but mostly HPV-
16 is the most common type of HPV related to OSCC. Other 
sub-types can also be found in the oropharyngeal region.
Oral squamous-cell carcinoma in the mouth floor is related 
to HPV-16. Simonato et al. studies performed on mouth 
floor SCC using nested polymerase chain reaction (nPCR) 
seem to confirm that HPV-DNA is related to OSCC, and was 
presented in 17.2% within 29 paraffin-embedded speci-
mens of mouth floor SCC [49]. All were diagnosed in men 
with clinical stage of III–IV lesions, but due to low presence 
of virus, it seems that it does not have a role on its own 
to induce an SCC, which might lead to a suggestion that 
only all risk factors combined together are related to OSCC. 
Nevertheless, a small amount of patients suffering from 
OSCC do not use either tobacco or alcohol, and tumors are 
with unknown etiology. Studies have shown that patients 
with HPV-DNA-positive tumors have 59% reduction in risk 
of cancer death compared to HPV-DNA-negative tumor 
patients. Moreover, HPV is more common in oropharynx 
SCC during more advanced clinical stages. In our opinion, 
based on the literature HPV could be a potential co-factor 
taking part in OSCC prognosis.
Gillison and Lowy conclude that in addition to alcohol 
and tobacco, HPV is an important agent for some HNSCC 
[17]. Indian research performed by Mondal et al. indicates 
that low levels of mtDNA (mitochondrial DNA, detected 
using PCR study with detection for GSTM1-GSTT1 poly-
morphism) content in tumors related to tobacco-betel 
quid chewing suggest an important marker in diagnos-
ing invasive OSCC [36]. On the other hand, Song reported 
that microRNA in HPV is an important factor of OSCC, and 
microRNA polymorphisms may modify the association 
between HPV-16 and OSCC risk [52]. These findings may 
lead to a conclusion that microRNA may modify the risk 
of HPV-16 related oral SCC in patients with oropharyngeal 
SCC and in never smokers. Only in some cases mostly HPV-
16 might be found in HNSCC. A higher amount of copies 
mostly can be found in the oropharynx region (posterior 
lingual and palatine tonsils) [52]. HPV-associated HNSCC 
are more frequent in non-smoking and in younger patients 
than in HNSCC not associated with HPV [50]. Vargas-Fer-
reira et al. stated that oral SCC is the fifth most common 
cancer type, and tobacco and alcohol are the main etio-
logical factors, but at least 15-20% of all OSCC occurs in 
patients without any risk factors [48, 59]. Some etiology 
of OSCC still remains unknown, but HPV-related infections 
seem to be more related to women or bisexuals [22, 54]. 
Nevertheless, HPV infections are a very important factor 
related to oral SCC. PCR diagnostics should be routinely 
performed in patients with SCC.
Geographic regions and genetic predispositions are con-
sidered as important factors in HPV infections.
Oral cavity cancer in Taiwan is common in middle aged 
men. Huang et al. in a group of 103 patients tried to find 
relations with HPV infection and OSCC. 30.1% of patients 
were positive for HPV infections with HPV-16 in about 
51.6% and HPV-18 in 22.6% [21]. According to studies, HPV-
16 was not related to tumor aggressiveness, risk exposure 
or treatment outcome, but HPV-18 showed statistically 
more cases with second primary cancers (SPC). A very 
important issue is that HPV infections noted by Huang in 
head and neck cancers may be different among anatomi-
cal subsites of diseases and HR-HPV-18 (high-risk) has a 
42.9% potential of occurrence of secondary primary tu-
mors in OSCC.
Studies performed by Chow et al. in a 30-year time frame 
show that in patients younger than 20 years SCC were di-
agnosed in three to fourteen patients [61]. In laryngeal 
tumors more of them were positive for HPV-16, and were 
treated with radical surgical resection with radio- or che-
motherapy. In fewer cases in children EBV virus was pres-
ent. Children receiving bone marrow transplant (BMT) 
developed SCC earlier than those without BMT. Because of 
more cases with nasopharyngeal carcinomas (NPC) found 
in younger women, a potential epidemic should be con-
sidered [29, 40]. Very rare tumors in children are still a 
diagnostic and clinical problem. In patients with any his-
tory of immunosuppression, tumors, radiotherapy or even 
genetic predisposition to malignancies, it is very impor-
tant to perform biopsies early. In younger patients some 
authors claim to have found relations between HPV and 
spinocellular carcinoma of the mouth, although Praetorius 
HPV-DNA research studies on oral spinocellular carcinoma 
(CEC) might suggest some differences [43]. Education of 
children on sexual behavior and early vaccination seems 
to be a rational way of decreasing HPV infections.
The region of head and neck is anatomically different from 
other parts of the human body. Because of the presence 
of many anatomical structures, and also the upper part of 
the digestive and respiratory system a careful examination 
should be performed in order to properly diagnose and 
evaluate this region.
Cancers of the upper aero-digestive tract (UADT) are in-
volved in relation to HPV. Anantharaman et al. in the AR-
CAGE study performed on 1496 cancer patients and 1425 
control group patients tried to associate specific HPV an-
tibodies [2]. HPV-16L1 was most common in oral and oro-
pharyngeal cancer, HPV-16E6 antibodies were present in 
30.2% of oropharyngeal cases and just 0.8% of control sub-
jects. Combined E6 and E7 antibodies seropositivity was 
rare. HPV-18 was associated with oropharyngeal cancer 
and HPV-6 with laryngeal cancer. In the study 47 tumors 
were positive for HPV-DNA, with 93.6% of HPV-16, HPV-31 
4.2%, HPV-33 12.8%, HPV-35 4.2% and HPV-66 2.1%. HPV-
16 E6 antibodies in UADT seem to be an important marker 
in identifying HPV-16 DNA.
Another condition related to HPV infection is recurrent 
respiratory papillomatosis (RRP). HPV-6 and HPV-11 along 613
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larynx and/or vocal cords can cause RRP. It is well known 
for many benign growths in the middle and lower part 
of the respiratory tract. According to Larson et al., it is 
present in 0.504 per 100 000 cases [28]. Papillomas tend to 
grow inside the vocal tract slowly, and despite their sur-
gical removal they tend to grow back slowly over a period 
of years. RRP can be fatal because it may cause respira-
tory obstruction. In juveniles RRP is common in children 
under five years of age, and might be related to vertical 
transmission from older parents or family members. RRP 
present in older people is observed from 20-40 years old 
and might be HPV-related non-cervical disease and has not 
been included in a vaccine [11]. HPV vaccines to prevent 
non-cervical HPV-related cancers are still not tested and 
it is not yet confirmed if they are helpful in for example 
HNSCC [16]. 
Patients suffering from HNSCC are at risk of second pri-
mary malignancies (SPM). The most common sites of di-
agnosed SPM are head and neck or lungs and esophagus 
[30]. Studies performed by Morris et al., in the past twenty 
years, suggest that the SPM site for patients with oral cavi-
ty and oropharynx SCC was head and neck, and for patients 
with laryngeal and hypopharyngeal cancer it was the lung 
[39]. Nowadays because of many HPV-related infections, 
risk of SPM related to SCC oropharyngeal is very low in 
any subsites. Despite that, complete surgical evaluation 
of each anatomical region should be performed. The au-
thors used the data from The National Cancer Institute’s 
Surveillance, Epidemiology, and End Results (SEER) from 
years 1975 to 2006, gathering a total of 75 087 occurrences 
of HNSCC. The study shows that SPM risk was highest for 
index hypopharyngeal cancers. The authors hypothesize 
that patients with HPV-associated oropharyngeal SCC may 
have lower SPM risk [53].
Molecular studies performed in HPV virus and its influ-
ence on SCC seem to explain more often the nature of 
the virus, its structure and presence of antibodies. Im-
munohistochemical findings are very important factors 
related to proper treatment. Due to those studies, often 
performed chemotherapy and radiotherapy in SCC can be 
more accurate.
Lopes et al. made an attempt to establish the prevalence 
and relations of HPV-16 and HPV-18 subtypes in oral SCC 
in a study group of 142 using PCR and Q-PCR (type-specific 
quantitative PCR) [33]. During this study two files contain-
ing HPV-16 and two with HPV-18, but only two with HPV-
16 had moderate viral loads with 51 and 91 viral copies 
per cell respectively and were positive for HPV DNA virus. 
Other cases had very low viral loads and lacked HPV DNA 
tumor cells. Because of that, Lopes et al. suggest that on-
cogenic HPV is uncommon in oral SCC, but only high vi-
ral loads were positive by consensus PCR. Because of little 
evidence that high-risk HPV is related to oral SCC, routine 
testing for oral cancers related to HPV is not justified, but 
vaccination against HPV against oropharyngeal cancers 
might show some protection; therefore any protection for 
oral cancers is in vain. Marur et al., on the other hand, em-
phasize that oropharyngeal cancer is distinct with P53 deg-
radation, retinoblastoma RB pathway inactivation and P16 
upregulation, but tobacco-related oropharyngeal cancer 
is characterized by TP53 mutation and downregulation of 
CDKN2A encoding P16 [35]. Therefore HPV-positive HNSCC 
seems to be more responsive to chemotherapy and radia-
tion than HPV-negative disease. P16 could be useful as a 
marker for HPV status, but only after proper patient life 
style evaluation can direct laboratory and immunohisto-
chemical diagnoses be performed.
The molecular profile of HPV-related HNSCC is different 
in HPV positive and negative HNSCC. TP53 protein and E6 
oncoprotein are common with HPV-related HNSCC along 
with high levels of p16 tumor-suppressor protein. In HPV-
negative cases p16 is not fully expressed. Klussmann et al. 
discovered that high prevalence of p16 protein correlates 
strongly with presence of HPV during PCR testing, and is 
evidence of the presence of HPV DNA in a diagnosed tu-
mor [23]. Molecular findings in various studies show that 
despite many findings, HPV virus still has a lot of unknown 
variables. The molecular role of HPV in pathogenesis of 
oropharyngeal squamous-cell carcinoma was investigated 
by D’Souza et al. in a study group consisting of 100 patients 
with newly diagnosed oropharyngeal cancer and 200 con-
trol patients without cancer [8]. Many sex partners, espe-
cially a high amount of oral sex partners, was associated 
with oropharyngeal cancer and was significantly high with 
HPV-16 infection. Any oral infections with any of 37 types 
of HPV were seropositive for the HPV-16 L1 capsid protein. 
This protein was also associated with subjects with a his-
tory of tobacco and alcohol use and among those without 
such history. In addition, tobacco and alcohol seem to be 
the main factors of HNSCC but HPV-16 infection can addi-
tionally lead to it. Increasing cancers of tonsils and tongue 
base are related to increasing sexual practices. Vaccination 
of young boys and girls should lead in future to decrease 
of HPV-16 infections.
In most cases the standard PCR protocol is used in order 
to find and diagnose HPV infection, but other methods 
are also used quite often. Because of methods’ limitations, 
their costs and patient acceptance, not always can better 
diagnostic methods be performed.
Studies by Morbini et al. performed on 56 patients diag-
nosed with head and neck neoplastic and preneoplastic 
lesions suggest high sensitivity of the Genotyping Extra 
assay (SPF10 LiPA), which is a great alternative for rec-
ognizing and identifying viral types of HPV in patients 
with head and neck cancers [37]. Tumor tissues or oral 
exfoliated cells can be used in order to diagnose HPV. The 
authors used buccal scrapes and prepared them for anal-
ysis. DNA HPV assay allows one to detect high-risk (HR), 
low-risk (LR) and unclassified types of HPV. HPV DNA was 
identified in larynx, tongue, oropharynx, mouth floor and 
hypopharynx with overall infection of high-risk HPV be-
ing 96.43%. The study shows that this diagnostic method 
is highly effective in identification and characterization of 
DNA HPV presented in selected cases. HR HPV infections 614
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in head and neck can be more precisely diagnosed than 
when using other standard PCR methods. 
All over the world, national research teams are working 
on HPV infection related cancers. From a practical point 
of view, it seems to be a great idea, because of geographi-
cal and cultural differences. 
A Swedish study performed on 160 samples from patients 
diagnosed in 2000-2008 in Stockholm performed by Du 
et al. suggested that HPV-16 is associated with both cer-
vical and tonsillar cancer lesions are variants of amino 
acid sequence of E6 oncoprotein [12]. Diagnosis of tonsil-
lar squamous cell carcinoma (TSCC), cervical cancer (CC) 
and cervical samples (CS) shows that E6 variant R10G in 
HPV-16 was observed in TSCC but not in patients with CC. 
Studies revealed that special variants of HPV-16 especially 
L83V differ geographically but its prevalence is higher in 
TSCC compared to CC and CS. Quite an important factor 
is disease-free survival (DFS), defined as time from date 
of diagnosis to last known occasion that the patient was 
disease-free or the date of disease recurrence. 
Greek studies performed by Kouvousi et al. on 45 patients 
suffering from OSCC revealed that HPV-DNA was detected 
in 11.1% and HR-HPV in 6.7% of OSCC [25]. In 64 cytological 
samples 35 were from tongue, and the lowest number, 3, 
from buccal mucosa, which seems to be in line with WHO 
findings. E6/E7 mRNA expression from HR-HPV types (16, 
18, 31, 33 and 45) was found in 8.9% of samples. Still HPV-16 
is the most commonly found and in this case was present in 
3 out of 5 cases. Protein findings in HPV-related infections 
might lead to discovery of new vaccines. Poljak’s review of 
20 years of human papillomavirus research shows that L2 
protein of HPV-16 at lysine 35 regulates the expression of 
a small ubiquitin-related modifier, which shows the com-
plex interactions between HPV and host cell machinery 
[41]. This might lead to development of treatment focused 
on viral infections and HPV-induced cancers. Still more 
studies are taking place, but at this place lesions of cervi-
cal cancers with high-grade CIN and expression of HPV E7 
are targeted with HPV therapeutic vaccines. Perhaps due 
to this study oral HPV and its cancerous predispositions 
might be cured. 
Oral leukoplakia related to tobacco and alcohol is also re-
lated to HPV infections. In etiology of leukoplakia oth-
er infectious diseases and other irritant factors should 
be considered. The study by Majmumder et al. on XRCCI 
polymorphisms in DNA repair loci might modulate risk of 
tobacco-related leukoplakia and cancer in HPV patients, 
but further studies need to be performed. HPV infections 
significantly increase leukoplakia in HPV non-infected 
individuals [34]. 
Genetic findings and gene therapy related findings are 
still not yet fully used, although their value in success-
ful therapy is very important. Gene expression profiles in 
HPV positive and negative oropharyngeal cancer in 119 
patients with primary OSCC made by Lohavanichbutr et 
al. show that DNA HPV-16 virus was found in 34.5% in all 
studied cases [32]. Higher prevalence of HPV was found 
in oropharyngeal cancer than in oral cavity cancer, and 
no difference between gene expressions in positive and 
negative forms of HPV. Those findings also reported che-
mosensitivity to some chemotherapeutic agents used for 
treatment of HNSCC. Treatment of oropharyngeal cancer 
based on HPV status and efficacy of cisplatin, 5-fluorouracil, 
paclitaxel and irradiation seems to be one way to properly 
manage patients with SCC.
The WHIM syndrome (warts, hypogammaglobulinemia, in-
fections, myelokathexis) seems to be related to OSCC. This 
very rare syndrome is an example of the possibility that 
many diseases might have multi-symptomatic represen-
tation. Cipriani et al. reported WHIM syndrome related to 
HPV SCC in two siblings [5]. WHIM is an autosomal domi-
nant disease related to chemokine receptor CXCR4 muta-
tion, and influences the immune function. Some studies 
have shown that WHIM syndrome might be related to oral 
HPV that would have further risk in OSCC.
I seem that not only standard therapies are accurate in 
threatening viral diseases. In studies performed on mice, 
some authors are researching different possible therapies. 
According to studies performed by Taguchi et al., using 
traditional Japanese herbal medicine, Juzen-taiho-to (JTT) 
and Hochu-ekki-to (HET), with combined Lactobacillus vac-
cine immunized orally in mice, they achieved an adjuvant 
effect on the mucosal type 1 immune responses to human 
HPV E7 [55]. 
concluSIonS
HPV testing for cervical cancer is very common. Testing 
for oral HPV in the oral cavity should be associated with 
HPV-HNSCC, but still no adequate way of testing and diag-
nosis may be found. Many authors claim that standard PCR 
methods are useful, but few cases seem to make the differ-
ence. HPV-16 is well known as a factor strongly related to 
HNSCC, but so far no accurate vaccine or treatment is fully 
known to minimize or reduce its occurrence. So far only 
HPV-16 vaccine on the female genital tract is effective [10, 
24]. Public awareness in patients of HPV and oral cancers is 
increasing slowly. Local dentists and general practitioners 
should inform each patient about dangerous sexual behav-
ior and methods of oral care and regular routine dental 
check-ups. Knowledge and education of patients should 
be an important factor in preventing HPV and other viral 
infections. Oral cancer screening for oral and oropharyn-
geal cancer should be performed regularly, and reduction 
of alcohol and tobacco should be advised [20, 42, 46, 56, 60]. 
Some presented oral diseases or lesions might be corre-
lated with HPV infections; therefore extended and precise 
diagnostics and patient evaluation should be performed. 
Patient’s education, routine check-ups, and promotion of 
safe sexual behaviors should be implemented.615
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